Notification of Issue of Securities - North America ESPP

07 April 2022
Issue of ordinary shares

This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in the Fisher & Paykel Healthcare Corporation Limited Employee Stock Purchase Plan.

Section 1: issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of Financial Product Ordinary shares
ISIN NZFAPE0001S2
Section 2: capital change details
Number issued 17,380
Nominal value (if any) Not applicable
Issue price NZD20.6975
Nature of the payment Not applicable
Amount paid up (if not in full) In full
Percentage of total class of Financial Products issued 0.00301%
For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable
Reason for issue and specific authority for issue 17,380 shares were issued to the Company’s North American employees accepting an offer to participate in the Fisher & Paykel Healthcare Corporation Limited Employee Stock Purchase Plan
Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. Total number of ordinary shares on issue after the issues disclosed in this notice (excluding Treasury Stock): 577,285,976
Treasury stock as at the date of this notice after the issues disclosed in this notice: 137,282
Total number of ordinary shares on issue after the issues disclosed in this notice (including Treasury Stock): 577,423,258
In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable
Specific authority for the issue Directors’ resolution, Listing Rule 4.6
Terms or details of the issue The ordinary shares issued rank pari passu with the existing ordinary shares
Date of issue 01 April 2022
Section 3: authority for this announcement
Name of person authorised to make this announcement Raelene Leonard
Contact phone number +64 9 574 0147
Contact email address [email protected]
Date of release via MAP 07 April 2022

---

Announcement PDF